losartan has been researched along with 12-hydroxy-5,8,10,14-eicosatetraenoic acid in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gonzales, N; Hornsby, PJ; Nadler, J; Natarajan, R | 1 |
| Gonzales, N; Lanting, L; Nadler, J; Natarajan, R | 1 |
| Gelband, CH; Posner, P; Sumners, C; Zhu, M | 1 |
| Cheng, YL; Wang, WN; Xu, HZ; Xu, ZG; Zhang, YY | 1 |
4 other study(ies) available for losartan and 12-hydroxy-5,8,10,14-eicosatetraenoic acid
| Article | Year |
|---|---|
Mechanism of angiotensin II-induced proliferation in bovine adrenocortical cells.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Adrenal Cortex; Angiotensin II; Angiotensin Receptor Antagonists; Biphenyl Compounds; Cell Division; Cells, Cultured; DNA Replication; Dose-Response Relationship, Drug; Flavanones; Flavonoids; Humans; Hydroxyeicosatetraenoic Acids; Imidazoles; Losartan; Protein Kinase C; Pyrazoles; Pyridines; Pyrimidine Nucleosides; Tetrazoles; Thymidine | 1992 |
Role of the lipoxygenase pathway in angiotensin II-induced vascular smooth muscle cell hypertrophy.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Analysis of Variance; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aorta; Arachidonate 12-Lipoxygenase; Arachidonate 15-Lipoxygenase; Biphenyl Compounds; Cells, Cultured; Dose-Response Relationship, Drug; Fibronectins; Flavanones; Flavonoids; Hydroxyeicosatetraenoic Acids; Hypertrophy; Ibuprofen; Imidazoles; Lipoxygenase Inhibitors; Losartan; Muscle, Smooth, Vascular; Pyridines; Swine; Tetrazoles | 1994 |
Chronotropic effect of angiotensin II via type 2 receptors in rat brain neurons.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; 5,8,11,14-Eicosatetraynoic Acid; Action Potentials; Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Angiotensin Receptor Antagonists; Animals; Animals, Newborn; Arachidonic Acids; Brain; Cytarabine; Enzyme Inhibitors; Imidazoles; Lipoxygenase; Lipoxygenase Inhibitors; Losartan; Nerve Tissue Proteins; Neurons; Okadaic Acid; Phosphoprotein Phosphatases; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Signal Transduction; Synaptic Transmission; Tetrodotoxin; Time Factors | 2001 |
Effect of angiotensin II type 1 receptor blocker on 12-lipoxygenase activity and slit diaphragm protein expression in type 2 diabetic rat glomeruli.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Arachidonate 12-Lipoxygenase; Cadherins; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diet, High-Fat; Kidney Glomerulus; Lipoxygenase Inhibitors; Losartan; Male; Membrane Proteins; Mice; Podocytes; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Streptozocin | 2016 |